Background Vaccines are a crucial component of the global efforts to control the spread of
COVID-19. Very little is known about COVID-19 vaccine responses in patients living with …

Aim This survey was conducted to evaluate COVID‐19 vaccination status in patients with
autoimmune rheumatic diseases (AIRDs). Our objectives were to study vaccine hesitancy …

Objective Rheumatic disease patients on certain immunomodulators are at increased risk of
impaired humoral response to SARS-CoV-2 vaccines. We aimed to identify factors …

Objective To assess the safety, immunogenicity and cellular responses following the
Moderna Spikevax primary series in rheumatic disease. Methods We conducted a 12-month …

Similarly to the general population, advanced age, comorbidities and chronic glucocorticoid
treatment (≥ 10 mg/day prednisoneequivalent) have been identified as negative prognostic …

Objective Anti-COVID-19 vaccines have proved to be effective and well tolerated. Great
attention is now being paid to the characterisation of possible adverse events associated to …

As COVID-19 gradually becomes endemic in many parts of the world, a silent epidemic of
post-COVID-19 condition is emerging. Post-COVID-19 condition comprises a constellation of …

The ongoing COVID‑19 pandemic continues to be a cause of unprecedented morbidity and
mortality. Vaccination provides a ray of hope as a powerful tool for reducing the poor clinical …

Objectives The aim of the present work was to explore the perspectives of Egyptian
Rheumatology staff members as regards the coronavirus disease-19 (COVID-19) vaccine …

Vaccines against coronavirus disease 2019 (COVID-19) have been distributed in most
countries for the prevention of onset and aggravation of COVID-19. Recently, there have …